Cross‐sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology
Abstract Introduction Structural magnetic resonance imaging is a marker of gray matter health and decline that is sensitive to impaired cognition and Alzheimer's disease pathology. Prior work has shown that both amyloid β (Aβ) and tau biomarkers are related to cortical thinning, but it is uncle...
Main Authors: | Brian A. Gordon, Austin McCullough, Shruti Mishra, Tyler M. Blazey, Yi Su, John Christensen, Aylin Dincer, Kelley Jackson, Russ C. Hornbeck, John C. Morris, Beau M. Ances, Tammie L.S. Benzinger |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
Subjects: | |
Online Access: | https://doi.org/10.1016/j.dadm.2018.02.003 |
Similar Items
-
Tau Filaments and the Development of Positron Emission Tomography Tracers
by: Michel Goedert, et al.
Published: (2018-02-01) -
Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective
by: Maria Ricci, et al.
Published: (2021-11-01) -
Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms
by: Chul Hyoung Lyoo, et al.
Published: (2018-01-01) -
Flortaucipir (tau) PET in LGI1 antibody encephalitis
by: Gregory S. Day, et al.
Published: (2021-02-01) -
Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimagingResearch in context
by: Stephanie Doering, et al.
Published: (2024-05-01)